Profound Medical Appoints Richard R. Fabian as President; CTO Role Created

What Happened

• Profound Medical Corp. announced on Sept. 1, 2026 (8-K filed Sept. 3, 2026) that the Board appointed Richard R. Fabian, age 59, as President effective Sept. 1, 2026. Mr. Fabian succeeds Mathieu Burtnyk, PhD, who moved into a newly created Chief Technology Officer role effective the same date. Fabian was President & CEO of FUJIFILM Sonosite, Inc. through June 2026 and previously held senior roles at Philips Healthcare and STERIS. The Company and Mr. Fabian entered an Employment Agreement dated Sept. 1, 2026.

Key Details

• Base salary: $550,000 per year; annual discretionary bonus up to 100% of base salary.
• Equity grants: 200,000 restricted share units vesting in three equal annual installments; options to purchase 475,000 common shares vesting over four years (25% after one year, then monthly over 36 months).
• Relocation/expenses: Company will lease a Toronto residence for Mr. Fabian during his first 12 months while he spends ~50% of his time at the Toronto office; $1,000 monthly car allowance.
• No related-party arrangements or family relationships reported; selection not made pursuant to any third‑party arrangement.

Why It Matters

• Leadership change: A new President with deep experience in point‑of‑care imaging and imaging‑guided therapy may influence strategy and operations; the prior President remains with the company as CTO, keeping technical continuity.
• Compensation and equity: The size of cash and equity awards (200K RSUs + 475K options) is material for investor consideration because it represents future dilution and management alignment.
• Operational signal: The company’s commitment to a Toronto office presence (residence lease and ~50% time on site) signals continued investment in that location and executive involvement there.